Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?

Raschi, Emanuel; Caraceni, Paolo; Poluzzi, Elisabetta; De Ponti, Fabrizio

Raschi, Emanuel; Caraceni, Paolo; Poluzzi, Elisabetta; De Ponti, Fabrizio.

Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna , Bologna, Italy.
Caraceni P; Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna , Bologna, Italy.
Poluzzi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna , Bologna, Italy.
De Ponti F; Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna , Bologna, Italy.

Expert Opin Drug Saf ; 19(10): 1367-1369, 2020 10.

Article in English | MEDLINE | ID: covidwho-729049

Subject(s)

Coronavirus Infections; Janus Kinase Inhibitors; Pandemics; Pneumonia, Viral; Azetidines; Betacoronavirus; COVID-19; Humans; Janus Kinase Inhibitors/adverse effects; Liver; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Janus Kinase Inhibitors Limits: Humans Language: English Journal: Expert Opin Drug Saf Journal subject: Pharmacology / Drug Therapy Year: 2020 Document Type: Article Affiliation country: 14740338.2020.1812191

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google